| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2009;119:1005-1012.)
© 2009 American Heart Association, Inc.
Vascular Medicine |
From the Department of Cardiology, Cardiff University (J.P.J.H.); Vascular Physiology Unit, Institute of Child Health (J.P.J.H., A.E.D., E.E., J.E.D.); and Department of Epidemiology and Public Health, University College (D.R.W., M.J.S., E.J.B., M.G.M.), London, UK.
Correspondence to Professor John Deanfield, Vascular Physiology Unit, Institute of Child Health and Great Ormond Street Hospital for Children NHS Trust, 30 Guilford St, London WC1N 3EH, UK. E-mail j.deanfield{at}ich.ucl.ac.uk
Received January 22, 2008; accepted December 10, 2008.
Background— Endothelial dysfunction develops early and has been shown to predict the development of clinical complications of atherosclerosis. However, the relationship between early endothelial dysfunction and the progression of arterial disease in the general population is unknown. We investigated endothelial dysfunction, risk factors, and progression of carotid intima-media thickness (cIMT) in late-middle-aged individuals at low to intermediate cardiovascular risk in a prospective study between 1997 and 2005.
Methods and Results— Brachial artery flow-mediated dilatation and cIMT were measured in 213 nonsmoking British civil servants recruited from a prospective cohort (Whitehall II study). Participants (age, 45 to 66 years) were free of clinical cardiovascular disease and diabetes mellitus. Risk factors and Framingham Risk Score were determined at baseline. cIMT was repeated 6.2±0.4 years later. At baseline, age, blood pressure, low-density lipoprotein cholesterol, and Framingham Risk Score correlated with cIMT. However, only flow-mediated dilatation, not risk factors or Framingham Risk Score, was associated with average annual progression of cIMT. This relationship remained significant after adjustment for risk factors whether entered as separate variables or as Framingham Risk Score. Further adjustment for waist circumference, triglycerides, and employment grade had no significant effect.
Conclusions— Systemic endothelial function was associated with progression of preclinical carotid arterial disease over a 6-year period and was more closely related to cIMT changes than conventional risk factors. Thus, the relationship between endothelial dysfunction and adverse outcome is likely to be due not only to destabilization of established disease in high-risk populations but also to its impact on the evolution of the atherosclerotic substrate. Flow-mediated dilatation testing provides an integrated vascular measure that may aid the prediction of structural disease evolution and represents a potential short- to intermediate-term outcome measure for evaluation of preventive treatment strategies.
Related Article:
This article has been cited by other articles:
![]() |
G. Atkinson, A. M. Batterham, M. A. Black, N. T. Cable, N. D. Hopkins, E. A. Dawson, D. H. J. Thijssen, H. Jones, T. M. Tinken, and D. J. Green Is the ratio of flow-mediated dilation and shear rate a statistically sound approach to normalization in cross-sectional studies on endothelial function? J Appl Physiol, December 1, 2009; 107(6): 1893 - 1899. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bass, A. L Hinderliter, and C. R Lee The Impact of Ezetimibe on Endothelial Function and Other Markers of Cardiovascular Risk Ann. Pharmacother., December 1, 2009; 43(12): 2021 - 2030. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Heiss, J. Balzer, T. Hauffe, S. Hamada, E. Stegemann, T. Koeppel, M. W. Merx, T. Rassaf, M. Kelm, and T. Lauer Vascular Dysfunction of Brachial Artery After Transradial Access for Coronary Catheterization: Impact of Smoking and Catheter Changes J. Am. Coll. Cardiol. Intv., November 1, 2009; 2(11): 1067 - 1073. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M Freeman and J. P J Halcox Vascular impact of progenitor cell mobilisation for cardiac repair post-myocardial infarction Heart, August 15, 2009; 95(16): 1301 - 1302. [Full Text] [PDF] |
||||
![]() |
J.-C. Tardif Angiotensin-converting enzyme inhibitors and atherosclerotic plaque: a key role in the cardiovascular protection of patients with coronary artery disease Eur. Heart J. Suppl., August 1, 2009; 11(suppl_E): E9 - E16. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ganz, J. E. Ho, and P. Y. Hsue Structural and functional manifestations of human atherosclerosis: do they run in parallel? Eur. Heart J., July 1, 2009; 30(13): 1556 - 1558. [Full Text] [PDF] |
||||
![]() |
J. Steffel and T. F. Luscher Predicting the Development of Atherosclerosis Circulation, February 24, 2009; 119(7): 919 - 921. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |